Clinical risk factors for fracture in postmenopausal osteoporotic women: A review of the recent literature

被引:27
|
作者
LaFleur, Joanne [1 ]
McAdam-Marx, Carrie [1 ]
Kirkness, Carmen [1 ]
Brixner, Diana I. [1 ]
机构
[1] Univ Utah, Pharmacotherapy Outcomes Res Ctr, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84108 USA
关键词
bone mineral density; epidemiology; fracture risk factors; osteoporosis;
D O I
10.1345/aph.1K203
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review recent literature regarding relationships among age, weight or body mass index (BMI), bone mineral density (BMD), maternal history of fracture, or personal prior history of fracture and fragility fractures in women with postmenopausal osteoporosis (PMO). DATA SOURCES: A MEDLINE database search (1995-June 30, 2007) was conducted to identify literature related to risk factors of interest for PMO-related fractures. STUDY SELECTION AND DATA EXTRACTION: Cohort studies, case-control studies, and meta-analyses that reported fracture outcomes were included if they provided an estimate of relative risk for at least 1 of the 5 selected clinical risk factors (CRFs) and studied women with PMO or stratified risk estimates by age and sex. Of 313 identified studies that evaluated fractures as an endpoint, 245 did not report risk estimates for a CRIF of interest and/or did not report data for a PMO population. DATA SYNTHESIS: In the 68 included articles, the risks associated with the evaluated CRFs were high and significant. Prior fracture was a strong predictor of fracture and increased risk up to 18 times. Each standard deviation below the referent mean for BMD was associated with an increased fracture risk of up to 4.0 times; maternal fracture history increased risk 1.3-2.9 times. Age (per 5 year increment) increased risk by 1.2-5.0 times; low weight or BMI inconsistently showed a 0.5-3.0 times greater risk. CONCLUSIONS: Low BMD is widely used as a diagnostic indicator for osteoporosis; however, other CRFs play an important role in determining fracture risk among women with PMO.
引用
收藏
页码:375 / 386
页数:12
相关论文
共 50 条
  • [41] Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
    E. V. McCloskey
    L. A. Fitzpatrick
    M.-Y. Hu
    G. Williams
    J. A. Kanis
    Archives of Osteoporosis, 2019, 14
  • [42] The Risk of Osteoporotic Forearm Fractures in Postmenopausal Women in a Siberian Population Sample
    Mazurenko, Elena
    Rymar, Oksana
    Shcherbakova, Liliya
    Mazdorova, Ekaterina
    Malyutina, Sofia
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 11
  • [43] Association of FLT3 Polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women
    Koh, Jung-Min
    Oh, Bermseok
    Lee, Jong-Young
    Lee, Jong-Keuk
    Kimm, Kuchan
    Park, Byung Lae
    Shin, Hyoung Doo
    Lee, Il-Kwon
    Kim, Hyeoung-Joon
    Hong, Jung-Min
    Kim, Tae-Ho
    Kim, Ghi Su
    Kim, Shin-Yoon
    Park, Eui Kyun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) : 1752 - 1758
  • [44] The Prevalence of Fibromyalgia in Postmenopausal Osteoporotic Women and to Determination of Related Risk Factors (Preliminary Study)
    Onat, Sule Sahin
    Delialioglu, Sibel Unsal
    Demir, Sibel Ozbudak
    Ozel, Sumru
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2014, 20 (01): : 1 - 5
  • [45] Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies
    Cappelle, S. I.
    Ramon, I.
    Dekelver, C.
    Rozenberg, S.
    Baleanu, F.
    Karmali, R.
    Rubinstein, M.
    Tondeur, M.
    Moreau, M.
    Paesmans, M.
    Bergmann, P.
    Body, J. -J.
    MATURITAS, 2017, 106 : 1 - 7
  • [46] An assessment tool for predicting fracture risk in postmenopausal women
    Black, DM
    Steinbuch, M
    Palermo, L
    Dargent-Molina, P
    Lindsay, R
    Hoseyni, MS
    Johnell, O
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (07) : 519 - 528
  • [47] Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?
    Iconaru, L.
    Moreau, M.
    Kinnard, V.
    Baleanu, F.
    Paesmans, M.
    Karmali, R.
    Body, J. J.
    Bergmann, P.
    JBMR PLUS, 2019, 3 (12)
  • [48] Risk factors and quality of life for the occurrence of hip fracture in postmenopausal women
    Chen, Fang-Ping
    Fu, Tsai-Sheng
    Lin, Yu-Ching
    Fan, Chih-Ming
    BIOMEDICAL JOURNAL, 2018, 41 (03) : 202 - 208
  • [49] Risedronate reduces the risk of first vertebral fracture in osteoporotic women
    Heaney, RP
    Zizic, TM
    Fogelman, I
    Olszynski, WP
    Geusens, P
    Kasibhatla, C
    Alsayed, N
    Isaia, G
    Davie, MW
    Chesnut, CH
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 501 - 505
  • [50] Fracture Risk Prediction Using BMD and Clinical Risk Factors in Early Postmenopausal Women: Sensitivity of the WHO FRAX Tool
    Tremollieres, Florence A.
    Pouilles, Jean-Michel
    Drewniak, Nicolas
    Laparra, Jacques
    Ribot, Claude A.
    Dargent-Molina, Patricia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (05) : 1002 - 1009